FDA Approves Exelon For Parkinson Disease Dementia
Filed in archive Drugs, Vaccines and Therapeutics by ruth on June 29, 2006

"It's been recognized for almost a decade that the dementia of patients with Parkinson's disease differs from the dementia of patients with Alzheimer's," said Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research, "but until now, there has been no treatment that has been shown to be effective specifically for the dementia associated with Parkinson's Disease. Today's approval of Exelon helps to fill this medical need."Exelon is a choline
esterase inhibitor, which works by increasing the levels on acetylcholine in the brain. It has already secured marketing authorization in Europe and according to a Forbes news report, has already been approved to treat Parkinson's Disease dementia in 14 other countries.Permalink: FDA Approves Exelon For Parkinson Disease Dementia
Tags:
parkinson alzheimer biotech disease dementia parkinson+disease disease+dementia exelon+parkinson
Trackback: http://www.creative-weblogging.com/cgi-bin/mt-tb.pl/26016






